At-Home Abortion Pill is 22 Times More Dangerous Than FDA Admits: Report

One in 10 women will experience a serious adverse health event when using the pills, a terrifying fact the pro-abortion industry refuses to disclose.

bombshell report reveals that abortion pills marketed and mailed to woman as DIY abortion drugs is 22 times more dangerous than the Food & Drug Administration (FDA) admits.

The shocking finding, published by the Foundation for the Restoration of America (FFROA), uses real-world health insurance claims data to expose the abortion industry’s lie that the drugs mifepristone and misoprostol are safe for women.

In reality, one in ten women who take these at-home abortifacients will suffer sepsis, blood transfusion, hospitalization, infection, hemorrhage, uterine rupture, ruptured ectopic pregnancy, or even death.

Among those who escape serious adverse events, a stunning 85% will experience nausea, fever, chills, vomiting, headaches, or diarrhea.

“These shocking findings should alert all women that the abortion pills are extremely dangerous to their well-being—a conclusion completely at odds with what the FDA tells us,” said Doug Truax, founder of FFROA. “Once again, we are learning that our government will put political ideology above science, data, and the health and safety of its citizens.”

FFROA is demanding the FDA immediately reevaluate its findings and calling for congressional hearings “to find out how they could have gotten it so wrong.”

Mifepristone and misoprostol are the key drugs used in chemical abortions, killing the fetus and forcibly expelling it from the uterus. Chemical abortion has exploded in use in recent years—representing 63% of all abortions in 2023, up from just 31% in 2014, and almost certainly driving the increase in abortions nationwide from 2020 to 2023.

Pro-abortion groups, including Planned Parenthood, have turned to mifepristone to continue the war on unborn Americans in the wake of the Supreme Court’s Dobbsdecision returning abortion laws to the states.

In Jan. 2023, the Biden FDA greenlit companies to distribute mifepristone by mail instead of visiting a clinic. That codified a 2021 decision by the Biden FDA that used COVID as an excuse to lift the in-person purchase requirement because of the drug’s “strong safety record.”

“Mifepristone is safe and effective, and must remain on the market,” Planned Parenthood blasted in 2023 after the Fifth Circuit Court of Appeals temporarily halted the drug’s FDA approval. Danco Laboratories, the highly secretive top producer of mifepristone (Mifeprex) in the country, was part of that lawsuit. The company does not publish the names of its executives, investors, or most employees.

As early as 2002, mifepristone and Danco Laboratories came under fire after six women who took the chemical abortion pill became ill. Two of them died. The company denied any connection to the drug.

Notably, mifepristone was initially developed in the 1990s with substantial funding from another titan of the abortion industry: Warren Buffett, whose foundation “helped finance the research and development of the [mifepristone] pills that induce abortion.” Buffett is perhaps the world’s most prolific funder of abortions, a fact little-known outside pro-life circles.

Danco’s development was also connected to the Population Council, a population control organization founded by eugenicists to push mass sterilization and vasectomies on poor non-white countries overseas, most notably India. The council reportedly raised funds from George Soros’ Open Society Foundations, the Packard Foundation (of Hewlett-Packard fame), and California’s Kaiser Family Foundation.

Another early funder was the Feminist Majority Foundation, a California leftist group that aggressively lobbied the Clinton and Bush FDA to overturn its ban on importing mifepristone—and succeeded in convincing Clinton to “promote the testing, licensing and manufacturing in the U.S. of mifepristone” in 1993.

Now it’s up to President Trump to roll back at-home abortions.

Source: Restoration News (April 29, 2025)